DCs are central to immune defenses in mammals. In mice, three subsets of DCs are resident of lymphoid organs ([@bib10]). Plasmacytoid DCs (pDCs) are professional producers of IFN-α and -β, contributing to immune defenses against viruses ([@bib2]). CD11b^+^ DCs preferentially prime CD4^+^ T cells and promote humoral immunity ([@bib8]; [@bib14]). CD8α^+^ DCs are endowed with a unique efficiency in priming CD8^+^ T cells and in cross-presenting exogenous antigens ([@bib8]; [@bib14]). CD8α^+^ DCs are required for the natural induction of strong CD8^+^ T cell responses against tumors ([@bib18]; [@bib35]) or West Nile virus ([@bib18]). Specific delivery of vaccine antigens to CD8α^+^ DCs is especially efficient for vaccination against intracellular pathogens or tumors ([@bib6]; [@bib30]). Therefore, identification of human DC subsets functionally homologous to mouse CD8α^+^ DCs (CD8α^+^-type DCs) should be a major step forward for the design of innovative vaccination or immunotherapeutic strategies against cancer or infections ([@bib10]). So far, no conserved marker has been identified to specifically and unambiguously define CD8α^+^-type DCs in several mammalian species. Although human BDCA3^+^ and mouse CD8α^+^ DCs express the C-type lectin CLEC9A, which is known to be involved in cross-presentation in mice, this marker is also found on some human CD14^+^ monocytes and on mouse pDCs ([@bib7]; [@bib21]; [@bib35]). It is of note that no orthologue of CLEC9A has been identified yet in non mammalian vertebrate species.

We have recently performed comparative genomics studies of human, mouse, and sheep DC subsets to help identify potential homologies between these cell types across mammalian species ([@bib34]; unpublished data). We found that human blood BDCA3^+^ DCs share a specific gene signature with mouse CD8α^+^ DCs and proposed that they could be human professional cross-presenting DCs ([@bib34]; [@bib10]). In this paper, we demonstrate that human BDCA3^+^ DCs are more potent than their BDCA1^+^ counterparts or than pDCs for CD8^+^ T cell activation through antigen cross-presentation. We established elsewhere that sheep lymph CD26^+^ DCs ([@bib16]) are also equivalents to mouse CD8α^+^ DCs based on gene expression and functions such as superior efficacy for presentation of soluble antigen to CD8^+^ T cells (unpublished data). In this paper, we identify the XC chemokine receptor 1 (XCR1) as the first universal marker specifically expressed by the CD8α^+^-type DCs from three different mammalian species: ovine CD26^+^ DCs, mouse CD8α^+^ DCs, and human BDCA3^+^ DCs. We show that the *Xcr1* gene is present and well conserved in all higher vertebrates from reptiles to human. The ligand of XCR1, chemokine (C motif) ligand 1 (XCL1), is specifically expressed by activated NK and CD8^+^ T cells in mouse and human. We show that *Xcl1* mRNA is stored selectively in memory CD8^+^ T cells, allowing them to rapidly produce high levels of this chemokine upon stimulation. Finally, we show that XCR1^−/−^ mice have decreased CD8^+^ T cell responses to *Listeria monocytogenes* (*Lm*) associated with higher bacterial loads early after infection. Overall, our study strongly suggests an important and conserved role in mammals for XCR1 in the cross talk between NK or CD8^+^ T cells and CD8α^+^-type DCs, identifying this molecule as a novel tool to survey and target the DCs endowed with the best cross-presentation capacity across species.

RESULTS
=======

Human BDCA3^+^ DCs are functional homologues of mouse CD8α^+^ DCs for cross-presentation
----------------------------------------------------------------------------------------

To assess the cross-presentation capacity of human BDCA3^+^ DCs, we purified these cells together with other types of DCs. BDCA1^+^ DCs, BDCA3^+^ DCs, and pDCs were magnetically enriched from PBMCs by negative selection and then positively sorted by flow cytometry as depicted in [Fig. 1 A](#fig1){ref-type="fig"}. The purity of sorted cells was \>95% as observed by postsorting FACS reanalysis. Sorted HLA-A2^+^ DC subsets were cultured with apoptotic uninfected, or chronically HIV-infected, H9 cells in the presence of maturation stimuli, poly I:C for BDCA3^+^ DCs, LPS or poly I:C for BDCA1^+^ DCs, and R848 for pDCs. They were then cultured with an HIV-1 Pol-specific CD8^+^ T cell line. To avoid viral replication, experiments were performed in the presence of Saquinavir, an HIV protease inhibitor ([@bib19]). BDCA3^+^ DCs induced 40% more IFN-γ ELISPOTs than poly I:C--stimulated BDCA1^+^ DCs or R848-stimulated pDCs and 60% more as compared with LPS-stimulated BDCA1^+^ DCs ([Fig. 1 B](#fig1){ref-type="fig"}). Therefore, as expected from their gene expression profile ([@bib34]; [@bib10]), human BDCA3^+^ DCs had higher cross-presentation capacities than other human blood DC subsets and represent functional homologues of mouse CD8α^+^ DCs for cross-presentation.

![**Human blood BDCA3^+^ DCs are endowed with a higher cross-presentation ability than BDCA1^+^ DCs and pDCs.** (A) Sorting of DC populations from PBMCs. First, CD3 and CD14-depleted PBMCs were gated based on SSC-W and SSC-A to exclude cellular doublets and on FSC-A and SSC-A. Next, CD19^−^HLA-DR^+^ events and CD14^−^CD16^−^ events were sequentially selected. HLA-DR^+^CD123^hi^ events, corresponding to pDCs, were then sorted and the remaining events falling in the HLA-DR^+^CD123^lo/−^ were distinguished for BDCA1^+^ DC and BDCA3^+^ DC sorting. Sorting gates are delineated by red lines. (B) Cross-presentation assay with human DCs. Purified BDCA1^+^ DCs, BDCA3^+^ DCs, and pDCs were cultured with apoptotic cells at a 1:1 ratio for 16 h in the presence of maturation signal, 100 ng/ml LPS, 10 µg/ml poly I:C, or 10 µM R848 as indicated. After loading, DCs were extensively washed and used (5,000/well) in a 16-h IFN-γ ELISPOT assay with HIV-specific CD8^+^ T cells lines as effectors (15,000/well). Data are presented as the mean and range of duplicate wells for one representative experiment of at least two.](JEM_20100223_RGB_Fig1){#fig1}

XCR1 is selectively expressed by mouse CD8α^+^, human BDCA3^+^, and sheep CD26^+^ DCs
-------------------------------------------------------------------------------------

Based on gene chip analyses, the expression of the *XCR1* gene is a selective marker for both human BDCA3^+^ DCs and mouse CD8α^+^ DCs when compared with a large panel of cell types, including other DC subsets, a variety of other leukocytes and of nonhematopoietic cells, and all types of tissue ([Fig. 2 A](#fig2){ref-type="fig"}). This contrasts with the markers currently used to identify these DC subsets, which are more broadly expressed as clearly evident for BDCA3 in human or CADM1 in human and mouse ([Fig. 2 A](#fig2){ref-type="fig"}). Further extending this striking convergent observation in mouse and human DCs, we found that in a distant mammalian species, i.e., sheep, the *XCR1* gene was also selectively expressed in the CD8α^+^-like skin lymph CD26^+^ DC ([Fig. 2 B](#fig2){ref-type="fig"}). Thus, among the genes differentially expressed between DC subsets in a conserved manner across the three mammalian species examined, the *XCR1* gene stands out as the most discriminating marker for mouse spleen CD8α^+^ DCs, human blood BDCA3^+^ DCs, and sheep lymph CD26^+^ DCs ([Fig. 2, A and B](#fig2){ref-type="fig"}). This is also the case for tonsil BDCA3^+^ DCs ([Fig. 2 A](#fig2){ref-type="fig"}, orange circle). *Xcr1* mRNA was also selectively expressed in CD11c^+^SIRPα^−^CD24^+^ cells from BM FLT3-L cultures ([Fig. 3 A](#fig3){ref-type="fig"}), which correspond to a subset of in vitro--derived DCs equivalent to spleen CD8α^+^ DCs which can be referred to as eCD8α^+^ DCs ([@bib29]).

![***Xcr1* gene expression by different subsets of immune cells isolated from mice, human, and sheep.** (A) Microarray analysis of the expression of the *XCR1*, *THBD* (*BDCA3*),*CADM1*, and *LILRA4* (*BDCA2*) human genes and of the *Xcr1*, *CD8a*, *Cadm1*, and *Siglech* mouse genes in 96 different cell types or tissues, in human (top) and mouse (bottom), respectively. The human data were retrieved from the GEO database, normal tissues and cell types from the GSE7307 dataset, PBMC-derived macrophages from GSE4883, monocyte-derived DCs from GSE7509, monocyte-derived macrophages from GSM213500, and alveolar macrophages from GSE2125, and blood and tonsil DC subsets were retrieved from the [E-TABM-34](http://www.ebi.ac.uk/microarray-as/ae/browse.html?keywords=E-TABM-34) dataset ([@bib25]) of the EBI ArrayExpress database. The data for the other leukocyte subsets directly isolated from normal human blood were described previously ([@bib13]; [@bib34]) and can be downloaded from <http://www-microarrays.u-strasbg.fr/files/datasetsE.php>. The data for the mouse were downloaded from the BioGPS public database (<http://biogps.gnf.org>). Green circles, pDCs (dark, blood; light, tonsil); red circles, mouse spleen CD8α^+^ DCs and human blood BDCA3^+^ DCs; orange circles, human tonsil BDCA3^+^ DCs; blue circles, mouse spleen CD11b^+^ DCs or human BDCA1^+^ DCs (dark, blood; light, tonsil); brown circles, mouse spleen; yellow circles, mouse lymph nodes; gray, all other cell types and tissues. Results are expressed as mean and SD for at least three independent values for most human data points. (B) *Xcr1* expression determined by real-time PCR on sorted mouse spleen DC subsets and sheep leukocytes. Mouse DCs were defined as lin^−^CD11c^+^Bst2^+^ for pDCs, lin^−^CD11c^+^Bst2^−^CD8α^+^ for CD8α^+^ DCs, and CD8α^−^ for CD11b^+^ DCs. Results are representative of at least two independent experiments. Sheep skin lymph CD1b^+^CD26^+^ and CD1b^+^CD26^−^ DCs were sorted by flow cytometry to \>99% purity. Sheep CD4^+^ T, CD8^+^ T, NK, and B cells were purified from afferent lymph, and CD14^+^ monocytes from blood, by flow cytometry sorting to \>95% purity. Results are mean ± SEM of triplicate real-time RT-PCR reactions and they are representative of two different sheep for lymphocytes and of three different sheep for DCs. (C) β-galactosidase expression in splenocytes from XCR1^+/+^ and XCR1^−/−^ mice. β-galactosidase expression was assessed by FDG staining. The results are shown from one mouse representative of at least eight animals studied in four independent experiments.](JEM_20100223_RGB_Fig2){#fig2}

![**XCR1 expression and functions on mouse DC subsets from BM FLT3-L cultures.** (A) DC subsets from FLT3-L BM cultures from C57BL/6Ncrl mice were sorted and examined by real-time PCR for expression of the *Xcr1* gene. (B) Transwell assay on DC subsets derived from FLT3-L cultures of XCR1^+/−^ and XCR1^−/−^ BM cells. Results are representative of two experiments and expressed as mean ± SEM from duplicate wells for each data point. eCD8α^+^: FLT3-L BM-DC equivalents to spleen CD8α^+^ DCs and defined as SIRPα^−^CD24^+^CD11c^+^ cells. eCD11b^+^: FLT3-L DC equivalents to spleen CD11b^+^ DCs and defined as SIRPα^+^CD24^−^CD11c^+^ cells. pDC: FLT3-L BM-pDC defined as CD11c^low^Siglec-H^+^ cells.](JEM_20100223_GS_Fig3){#fig3}

To assess XCR1 protein expression pattern on mouse leukocytes, we resorted to a reporter/knockout mouse strain expressing the β-galactosidase enzyme under the control of the *Xcr1* promoter. When total spleen leukocytes were isolated from XCR1^−/−^ mice and stained for β-galactosidase activity using fluorescein di-β-[d]{.smallcaps}-galactopyranoside (FDG) as a substrate, \>80% of the cells that stained positive with FDG were CD8α^+^ DCs, and \>75% of CD8α^+^ DCs were FDG^+^ ([Fig. 2 C](#fig2){ref-type="fig"}). Thus, *Xcr1* was confirmed to be expressed selectively by the majority of mouse CD8α^+^ DCs. Altogether, these results showed that XCR1 is a conserved and very discriminating marker for the identification of mouse, ovine, and human CD8α^+^-type DCs.

XCR1 protein is active on mouse CD8α^+^, human BDCA3^+^, and sheep CD26^+^ DCs
------------------------------------------------------------------------------

We then performed transwell migration assays with recombinant XCL1 and mixtures of the three subsets of mouse spleen DCs ([Fig. 4 A](#fig4){ref-type="fig"}) or their in vitro equivalents derived in BM FLT3-L cultures ([Fig. 3 B](#fig3){ref-type="fig"}). In both instances, XCL1 induced the specific migration of CD8α^+^-type DCs. Moreover, only XCR1^+/+^ and XCR1^+/−^ CD8α^+^ or eCD8α^+^ DCs were responsive to XCL1 ([Fig. 3 B](#fig3){ref-type="fig"} and [Fig. 4 A](#fig4){ref-type="fig"}), but not their XCR1^−/−^ counterparts, demonstrating that XCR1 is required for DC responses to XCL1. We then performed transwell assays with enriched DC preparations from human blood and sheep lymph. Only human BDCA3^+^ DCs and sheep CD26^+^ DCs, and none of the other leukocyte subsets tested, were found to migrate in response to XCL1 ([Fig. 4 A](#fig4){ref-type="fig"}). Therefore, XCR1 is required for DC responses to XCL1, and its engagement induces the selective motility of mouse, ovine, and human CD8α^+^-type DCs.

![**XCR1 is functionally active on mouse CD8α^+^, human BDCA3^+^, and sheep CD26^+^ DCs, and *Xcl1* mRNA is stored in quiescent NK cells and memory CD8^+^ T lymphocytes.** Transwell migration assay on enriched human blood DCs or lymphocytes, sheep lymph CD26^+^ versus CD26^−^ DCs, and splenic DCs from XCR1^−/−^ and C57BL/6NCrl (XCR1^+/+^) mice. Results are representative of at least two independent experiments for each species and expressed as mean ± SEM from duplicate wells for each data point. (B) Expression of the *XCL1* gene in human and mouse cell types and tissues, based on the same gene chips data as used in [Fig. 1 A](#fig1){ref-type="fig"}, with the following additions: black triangles, NK cells; purple triangles, resting peripheral CD8^+^ T cells; purple diamond, anti-CD3 activated human T cells; purple square, mouse CD8^+^ thymocytes; violet square, mouse CD4^+^ thymocytes. Results are expressed as mean and SD for at least three independent values for most human data points. (C) Expression of the *XCL1* gene in sheep leukocytes as assessed by real-time PCR on the same lymph or blood cells as shown in [Fig. 2](#fig2){ref-type="fig"}. Results are mean ± SEM of triplicate real-time RT-PCR reactions, and they are representative of two different sheep for lymphocytes and of three different sheep for DCs. (D) Results of *Xcl1* gene expression in mouse CD8^+^ T cell subsets. Xcl1 expression was measured by real-time PCR on sorted naive or T~IM~, or antiviral T~CM~ CD8^+^ T cell subsets. Expression of *Ccl5* and *Ifng* were also evaluated as controls, as the genes are expressed to higher levels in memory CD8^+^ T cells ([@bib42]). Results are represented as mean ± SD for mean values from duplicate real-time PCR reactions performed on mRNAs from naive T cells or from T~IM~ from three individual mice each, and from T~CM~ from four individual pools of seven mice.](JEM_20100223_RGB_Fig4){#fig4}

*Xcl1* mRNA is stored in quiescent NK cells and memory CD8^+^ T lymphocytes
---------------------------------------------------------------------------

XCL1 is produced and secreted specifically by activated mouse and human NK and CD8^+^ T cells ([@bib28]; [@bib11]), whereas no XCL1 protein is detected by intracellular staining in quiescent mouse NK cells ([@bib11]). The *Xcl1* gene is specifically expressed in NK and CD8^+^ T cells already at steady state not only in mouse and human ([Fig. 4 B](#fig4){ref-type="fig"}) but also in sheep ([Fig. 4 C](#fig4){ref-type="fig"}). Moreover, similar to what we previously reported for CCL5 ([@bib42]), we show that *XCL1* mRNA is selectively expressed to high levels in antiviral central memory CD8^+^ T lymphocytes (T~CM~s) and, to a lesser extent, in memory T cells induced by sterile inflammatory conditions (inflammatory memory CD8^+^ T cells \[T~IM~s\]; [Fig. 4 D](#fig4){ref-type="fig"}). Cytokine secretion profiling of the mouse CD8^+^ T cell subsets demonstrated a rapid and higher level secretion of XCL1 by T~IM~ after antigen-specific reactivation in vitro compared with naive CD8^+^ T cells (unpublished data). The selective expression of *Xcl1* in mouse T~CM~ was confirmed independently by mining published mouse microarray datasets retrieved through the GEO database ([@bib36]; [Fig. S1 A](http://www.jem.org/cgi/content/full/jem.20100223/DC1)). Therefore, *XCL1* mRNA is specifically expressed at steady state in NK and, to a lesser extent, CD8^+^ T cells, further induced in these cell types upon activation, including during viral infections in mouse and human (Fig. S1; [@bib22]; [@bib36]), and stored in T~CM~. Hence, XCR1 expression is likely integral to the unique potency of CD8α^+^-type DCs for interaction with NK and CD8^+^ T cells.

*Xcr1* is conserved in vertebrates and may be an ancient marker for CD8α^+^-type DCs.
-------------------------------------------------------------------------------------

Sequences similar to the *Xcr1* locus are available from many mammals including all the species with a full genome assembly. Only one gene per species was found, located in the same genomic region as several CC chemokine receptors (CCRs). A unique *Xcr1* sequence was also identified from genomes of birds and the Anole lizard. Several sequences similar to *Xcr1* were present in teleost fish, such as zebrafish and stickleback, but only one in others like Fugu. The *Xcr1* sequence is well conserved in all eutherian species examined (\>75% identity with the human sequence), in marsupials (∼70% identity), in birds and reptiles (60--65% identity), and in fish (50--60% identity; [Fig. S2](http://www.jem.org/cgi/content/full/jem.20100223/DC1)). These sequences were aligned with those of several human CCRs, and phylogenetic analyses were performed using different methods. Trees reconstructed were congruent and demonstrated that the *Xcr1*-like sequences found in the different vertebrate taxa are true orthologues of the mammalian *Xcr1* gene ([Fig. 5 A](#fig5){ref-type="fig"} and Fig. S2), which was confirmed by synteny ([Fig. 5, B and C](#fig5){ref-type="fig"}). The multiple genes found in fish probably derive from the complex history of fish genomes that have been marked by large duplication events, fast evolution, and extensive genome rearrangements ([@bib33]). It is remarkable that both stickleback *Xcr1* co-orthologues are closely linked to paralogues of the marker FYCO1, which is also encoded in the close neighborhood of mammalian *Xcr1* ([Fig. 5 B-C](#fig5){ref-type="fig"}). This conserved synteny indicates that the stickleback *Xcr1*-like genes indeed constitute valid co-orthologues of the mammalian receptor. Hence, XCR1 is a promising candidate marker to identify, isolate, study, and possibly target CD8α^+^-type DCs in all vertebrates.

![***Xcr1* evolution in vertebrates.** (A). Neighbor-joining (NJ) phylogenetic analysis. *Xcr1* sequences from selected vertebrate species were extracted from the Ensembl databases and aligned with relevant human CCR sequences using ClustalW. The evolutionary history was inferred using the NJ method. The bootstrap consensus tree inferred from 1,000 replicates is taken to represent the evolutionary history of the taxa analyzed. The percentages of replicate trees in which the associated taxa clustered together in the bootstrap test are shown next to the branches. The tree is drawn to scale, with branch lengths in the same units as those of the evolutionary distances used to infer the phylogenetic tree. The evolutionary distances were computed using the Poisson correction method and are in the units of the number of amino acid substitutions per site. All positions containing gaps and missing data were eliminated from the dataset (complete deletion option). There were a total of 267 positions in the final dataset. Phylogenetic analyses were conducted in MEGA4 ([@bib40]). Abbreviations for species are: HS, *Homo sapiens* (Ensembl ID: ENSG00000173578); BT, *Bos taurus* (ENSBTAG00000020019); MM, *Mus musculus* (ENSMUSG00000060509); FR, *Fugu rubripes* (ENSTRUG00000012394); GG, *Gallus gallus* (ENSGALG00000011735); MD, *Monodelphis domestica* (ENSMODG00000024025); TG, *Taeniopygia guttata* (ENSTGUG00000004516); DR, *Danio rerio* (ENSDARG00000054847, ENSDART00000077124, and ENSDART00000074943); and GA, *Gasterosteus aculeatus* (ENSGACG00000011742 and ENSGACG00000017177). Human CCR IDs are as follows: CX3CR1 (ENSG00000168329); CCR8 (ENSG00000179934); CCR4 (ENSG00000183813); CCR1 (ENSG00000163823); CCR3 (ENSG00000183625); CCR2 (ENSG00000121807); and CCR5 (ENSG00000160791). (B) Map of the human genes in the vicinity of the *XCR1* gene. (C) Conserved syntenies retrieved in different vertebrates in the neighborhood of *Xcr1*. Abbreviations for species are the same as in A. The locations of the genes are given as the number of the corresponding chromosome (for mammals and birds) or linkage group (for teleost), followed by a colon and the position of the sequence in base pairs on the chromosome/group.](JEM_20100223_GS_Fig5){#fig5}

XCR1 promotes induction of CD8^+^ T cell responses and control of bacterial load in vivo early during *Lm* infection
--------------------------------------------------------------------------------------------------------------------

CD8α^+^ DCs, but not CD11b^+^ DCs or pDCs, isolated from mice infected with *Lm* present bacterial antigens for the priming of naive CD8^+^ T cells ([@bib3]). Treatment of *Lm*-infected mice with pertussis toxin compromises the later activation of adoptively transferred antibacterial CD8^+^ T cells ([@bib1]). Pertussis toxin is a nonspecific inhibitor of G proteins that is widely used to inhibit chemokine receptor signaling. Thus, it was suggested that a chemokine receptor expressed on DCs is required to enable them to induce CD8^+^ T cell responses to *Lm* infection. We reasoned that XCR1 could contribute to this process. Therefore, we challenged XCR1^−/−^ and XCR1^+/+^ mice with *Lm* to evaluate the impact of XCR1 deficiency on the control of the bacteria load and on the induction of CD8^+^ T cell responses ([Fig. 6](#fig6){ref-type="fig"}). As compared with XCR1^+/+^ mice, XCR1^−/−^ animals infected with WT *Lm* displayed a log increase in their bacteria loads measured in livers and spleens at day 3 after inoculation ([Fig. 6 A](#fig6){ref-type="fig"}). There was still a trend toward higher bacterial loads in the spleen and liver of XCR1^−/−^ mice at day 4 after inoculation, although it was weaker than at day 3 (unpublished data). Because anti-*Lm* CD8^+^ T cell responses are readily detectable at 3--4 d after infection ([@bib24]), their alteration in XCR1^−/−^ animals could contribute to the higher bacterial replication in these animals. To compare the levels of anti-*Lm* CD8^+^ T cell responses between XCR1^−/−^ and XCR1^+/+^ mice, they were infected with a recombinant *Lm* strain expressing the ovalbumin antigen (*Lm*-OVA), and anti-OVA CD8^+^ T cells were enumerated by MHC class I tetramer staining at day 4 after inoculation. XCR1^−/−^ mice exhibited significantly fewer anti-*Lm* CD8^+^ T cells than XCR1^+/+^ animals ([Fig. 6 B](#fig6){ref-type="fig"}). Thus, these data suggest that XCR1 activity in CD8α^+^ DCs allows them to more efficiently induce antigen-specific CD8^+^ T cell responses and, hence, promote bacteria control early after infection with *Lm*.

![**XCR1 deficiency affects *Lm* control and antibacterial CD8^+^ T cell responses early after infection.** (A) Bacterial loads in the spleen and liver of XCR1^−/−^ versus XCR1^+/+^ mice at day 3 after infection. Results are represented as mean ± SEM for three animals per group and from one representative experiment out of two. (B) Frequency of anti-OVA(SIINFEKL) tetramer^+^ cells within total spleen CD8^+^ T lymphocytes from *Lm*-OVA--infected mice at day 4 after infection. Results are represented as mean ± SEM from two independent experiments pooled for statistical analysis. \*\*\*, P \< 0.005 using an unpaired Mann-Whitney non parametric test, eight mice per group.](JEM_20100223_GS_Fig6){#fig6}

DISCUSSION
==========

The demonstration that human blood BDCA3^+^ DCs isolated ex vivo are more potent than their BDCA1^+^ counterparts or pDCs for antigen cross-presentation and CD8^+^ T cell activation fulfills our prediction, based on our comparative genomics studies, that human BDCA3^+^ DCs represent, in this respect, a functional homologue of mouse CD8α^+^ DCs and an interesting target for the design of innovative vaccination or immunotherapeutic strategies against infections by intracellular pathogens or cancer ([@bib34]; [@bib10]). More generally, our results demonstrate a common specialization of mouse CD8α^+^, human BDCA3^+^, and sheep CD26^+^ DCs for CD8^+^ T cell activation through cross-presentation of exogenous antigens and identical high selective expression of XCR1 by these cells that is consistent with the role of this molecule in the promotion of the interactions between CD8α^+^-like DCs and CD8^+^ T cells. These results establish a definitive proof of concept that validates our comparative genomics approach to hunt for conserved functions based on conserved molecular pathways for DC subsets across several mammalian species ([@bib34]; [@bib10]).This work exemplifies how critical knowledge can be gained to understand important immunological processes by using comparisons between species as a tool and by developing tight collaborations between teams working with different animal models. In particular, this work illustrates the utility of nonprimate animal models for understanding human immunology, provided that a rational approach is followed to help focusing on conserved biological processes and molecular functions.

Based on gene chip analyses, we previously reported that mouse CD8α^+^ DCs specifically expressed the *Xcr1* gene, to high levels, whereas none of the other leukocyte subsets examined did. Indeed, in the Supplemental material of our paper ([@bib34]), we reported *Xcr1* as the third most specific gene for mouse CD8α^+^ DCs in our analyses. This result was confirmed and significantly extended by [@bib12]. Indeed, these authors additionally reported that XCR1 engagement induces calcium mobilization specifically in CD8α^+^ DCs and that XCL1 responses are required for the induction of optimal primary CD8^+^ T cell responses by CD8α^+^ DCs in response to soluble model antigens in vitro and in vivo. No functional ProbeSet specific for the human *XCR1* gene had been identified on the Affymetrix Human Genome U133 Plus 2.0 Array until very recently. XCR1 was, therefore, not reported by us ([@bib34]) or by [@bib12] to be specifically expressed in human BDCA3^+^ DCs. However, by mapping on the human genome all individual orphan ProbeSets that were giving a high and specific signal only in human BDCA3^+^ DCs as compared with other blood leukocyte subsets, we identified that the 1561226_at ProbeSet mapped to the human XCR1 gene, which was later confirmed by the November 2009 update of the Ensembl genome browser. Hence, we demonstrate in this paper, for the first time, to the best of our knowledge, a conserved specific expression and activity of XCR1 on CD8α^+^-type DCs derived in vitro in mouse BM FLT3-L cultures or isolated ex vivo from human and sheep. In our hands, XCL1 did not induce any maturation of DCs, either alone or in combination with IFN-γ, and did not seem to affect TLR-induced maturation of DCs in vitro (unpublished data). We confirm the specific expression of XCR1 ligands in NK cells and CD8^+^ T lymphocytes in mouse and human and extend it to sheep. We show that *Xcl1* mRNA is stored in quiescent NK cells and antiviral memory CD8^+^ T lymphocytes. We show that XCR1 promotes the induction of CD8^+^ T cell responses and the control of bacterial load in vivo early during *Lm* infection. Our phylogenetic analyses show the presence of a unique and well conserved XCR1 orthologue in all higher vertebrates from reptiles to human. Altogether, these observations strongly suggest that the XCL1→XCR1 chemotactic pathway constitutes one of the critical and conserved molecular bases promoting selective and efficient cross talk between CD8α^+^-type DCs and CD8^+^ T lymphocytes as well as NK cells.

In summary, our results demonstrate a functional homology between mouse CD8α^+^, sheep CD26^+^, and human BDCA3^+^ DCs and identify XCR1 as the best candidate to date for the identification of CD8α^+^-type DCs in all vertebrates, with a very narrow expression pattern highly restricted to these cell types. In addition, we show that, contrary to the molecules classically used to identify CD8α^+^-like DCs, XCR1 is not a mere phenotypical marker of these cells but actually contributes to confer on them their exquisite ability for CD8^+^ T cell activation. Thus, our study brings significant advances toward the generation of a unifying phenotypic and functional view of mammalian DC subsets, with major implications both for basic and applied immunology. Our findings open a way for the general survey by immunohistofluorescence of the anatomical location of CD8α^+^-type DCs and for their specific targeting in vivo for vaccination against intracellular pathogens or tumors threatening human or domestic animal health.

MATERIALS AND METHODS
=====================

### Cell purification and culture for human DC subset cross-presentation assay.

For each experiment, \>500 × 10^6^ PBMCs were isolated by Ficoll-Hypaque density gradient centrifugation (GE Healthcare) from peripheral blood cytapheresis residues obtained from normal healthy volunteer donors through the Etablissement Français du Sang according to the French ethics committee on human experimentations, within a convention with Institut National de la Santé et de la Recherche Médicale. Primary DCs (BDCA1^+^ DCs, BDCA3^+^ DCs, and pDCs) were isolated from PBMCs depleted of CD3^+^ and CD14^+^ cells using CD3^+^ and CD14^+^ MACS microbeads and an AutoMACS (Miltenyi Biotec). Enriched cells were labeled and DCs were sorted on a FACSAria flow cytometer (BD) as events negative for CD14, CD16, and CD19 and positive for HLA-DR and BDCA1 for BDCA1^+^ DCs, HLA-DR and BDCA3 for BDCA3^+^ DCs, or HLA-DR and CD123 for pDCs. The following antibodies were used: HLA-DR-PerCp (G46-6), CD14-PE-Cy7 (M5E2), CD16-APC-H7 (3G8; all obtained from BD), CD19-ECD (J3-119; Beckman Coulter), BDCA1-Pacific Blue (L161; BioLegend), BDCA3-APC (AD5-14H12), and CD123-PE (AC145; both obtained from Miltenyi Biotec). Cell sorting gave a purity \>95%. CD8^+^ primary T cell lines specific for the HLA-A2--restricted HIV-Pol~476-84~ epitope were generated as previously described ([@bib19]) using PBMCs from HLA-A2^+^ HIV^+^ individuals from a cohort study with the approval of Cochin Hospital's ethics committee. They were cultured in the presence of 1 µM Pol~476-484~ in complete medium (CM; RPMI 1640--GlutaMAX containing 100 U/ml penicillin, 100 mg/ml streptomycin, 1% nonessential amino acids, 1 mM sodium pyruvate, and 10 mM Hepes buffer; Life Technologies) + 5% human serum (BioWest) and maintained for 4 wk at 0.7 × 10^6^--10^6^ cells/ml, adding 10 U/ml IL-2 (Roche) twice a week. Uninfected (American Type Culture Collection; HTB-176) or chronically infected (American Type Culture Collection; CRL-8543) HLA-A2^−^ H9 cells were UV-irradiated (400 mJ/cm^2^ at 312 nm) to induce their apoptosis and incubated at 10^6^ cells/ml for 2 h in CM + 10% FCS (Invitrogen). Purified BDCA-1^+^ DCs, BDCA-3^+^ DCs, and pDCs were cultured with apoptotic cells at a 1:1 ratio for 16 h in the presence of a maturation signal, 100 ng/ml LPS (Sigma-Aldrich), or 10 µg/ml poly I:C (InvivoGen) or 10 µM R848 (InvivoGen) in CM + 5% human AB serum. After loading, DCs were extensively washed and used (5,000/well) in a 16-h IFN-γ ELISPOT assay with HIV-specific CD8^+^ T cells lines as effectors (15,000/well). All cultures were performed in the presence of 1 µM Saquinavir (Roche), an HIV-protease inhibitor, to avoid HIV replication ([@bib19]).

### Animals.

C57BL/6Ncrl mice were provided by Charles River. XCR1^−/−^ mice (B6.129P2-*Xcr1^\<tm1Dgen\>^*/J mice; MGI:3604538) were generated by Deltagen. Frozen XCR1^+/−^ embryos were provided by The Jackson Laboratory for strain reviviscence in the Centre d'Immunologie de Marseille-Luminy (CIML). In these mice, the β-galactosidase is expressed under the *Xcr1* promoter and in place of *Xcr1*, which permits a detection of the natural expression pattern of *Xcr1*. All mice were kept under pathogen-free conditions in the CIML animal care facility. Mouse experiments were conducted in accordance with institutional guidelines for animal care and use (French Provence Ethical Committee Protocol no. 04/2005 and US Office of Laboratory Animal Welfare Assurance A5665-01). Sheep were cannulated at the Center of Research in Interventional Imaging, Institut National de La Recherche Agronomique-Assistance Publique Hôpitaux de Paris (Jouy en Josas, France) for collecting prescapular skin afferent lymph as previously described ([@bib37]), and the sheep were housed in the Domestic Animal Experimental Unit INRA (Paris-Sud ethic commitee no. 08002A, Jouy en Josas, France).

### Memory CD8^+^ T cell generation.

T~IM~s were generated by intraperitoneal injection of 50 nmol influenza A nucleoprotein NP366-374 in PBS in naive thymectomized transgenic F5 mice ([@bib27]). Antiviral T~CM~s were generated by immunizing F5 mice with a recombinant vaccinia virus including the NP68 epitope as previously described ([@bib9]). Spleens and lymph nodes were collected 6 wk after infection for cell preparation as described in the next section.

### Cell preparation, staining, and cell sorting for real-time PCR or transwell migration assay.

Mouse splenocytes were prepared and DC subsets sorted as described previously ([@bib34]). CD8^+^ T cells purified from mouse spleen and lymph nodes were stained for surface expression of CD44, CD8, and F5 TCR ([@bib41]). Naive CD8^+^ T cells, T~IM~, and antiviral T~CM~ were sorted by flow cytometry as CD8^+^/CD44^low^, CD8^+^/CD44^int^, and CD8^+^/CD44^high^/F5 TCR^+^, respectively. β-Galactosidase enzyme activity in splenocytes from XCR1^−/−^ mice was revealed using FDG as a substrate according to the manufacturer's instructions (Invitrogen). In brief, FDG was diluted in warm distilled water at 2 mM, and cells were mixed 1:1 with the substrate. After an incubation of one minute at 37°C, cells were placed on ice, and the enzymatic reaction was terminated by adding ice-cold PBS. Cells were stained with a marker of viability and promptly acquired by flow cytometry. Sheep CD4^+^ T, CD8^+^ T, NK, and B cells were enriched from afferent lymph, and monocytes were enriched from blood. Sheep leukocytes were stained with mouse mAbs against CD1b (clone TH97A; [@bib31]), CD26 (CC69; [@bib17]), CD8α (CACT80C; [@bib26]), CD4 (ST4; [@bib20]), CD14 (CAM36A; [@bib4]), and NKp46 (AKS4). AKS4 was produced against bovine NKp46 according to a previously described protocol ([@bib39]), and it cross reacts with ovine NK cells defined as CD16^+^/CD14^−^ blood leukocytes ([@bib15]). NKp46 has been shown to be the best discriminating and conserved marker for NK cell identification in mammals ([@bib39]; [@bib43]). The DU2-104 mAb is used to characterize all B cells in sheep ([@bib32]). Sheep cells were reacted with 2 µg/ml of primary antibodies, stained with fluorochrom-conjugated purified Ig directed to specific mouse isotypes, and sorted by FACS with \>95% purity.

### Microarray and real-time PCR experiments.

The generation and analysis of microarray data for mouse and human DC subsets were described elsewhere ([@bib34]; [@bib44]). All datasets used are public and their references for download from databases are given in the legends of figures. A compendium of human hgu133plus2 Affymetrix.CEL files was established, using Bioconductor (release 2.5) in the R statistical environment (version 2.10.1). This consisted of the quality control assessment using the AffyPLM package ([@bib5]; e.g., visual examination of hybridization chip images, relative log expression, and normalized unscaled standard errors plots) and the robust multichip analysis normalization ([@bib23]) with the Affy package. Normalized log~2~ scaled values were then averaged among replicate arrays for each probe, and standard deviations were calculated. For real-time PCR experiments, total RNA was prepared with either the RNA NOW reagent (Biogentex) for mouse CD8^+^ T cells or the RNeasy Isolation kit (QIAGEN) for mouse DCs. RNA was reverse transcribed into cDNA with the QuantiTect reverse transcription kit (QIAGEN), and the cDNA was analyzed by real-time PCR using the Power SYBR green PCR master mix (Applied Biosystems). Primers were as follows: mouse *Xcr1*, 5′-CTCAGCCTTGTGGGTAACAGC-3′ and 5′-ACAGGCAGTAGACAGGAGAAC-3′; mouse *Ccl5*, 5′-GCACCTGCCTCACCATATGG-3′ and 5′-AGCACTTGCTGCTGGTGTAG-3′; mouse *Ifng*, 5′-CCAGCGCCAAGCATTCAATGAG-3′ and 5′-GACAATCTCTTCCCCACCCCG-3′; mouse *ubiquitin*, 5′-AAGAATTCAGATCGGATGACACACT-3′ and 5′-GCCACTTGGAGGTTGACACTTT-3′; sheep *XCR1*, 5′-TGCCATCTTCCACAAGGTGTT-3′ and 5′-ACGGAGGCGAGGAACCA-3′; sheep *XCL1*, 5′-TGAGCCAGAGCAAGCCTACA-3′ and 5′-TCACTACCCAGTCAGGGTCACA-3′; and sheep *GAPDH*, 5′-CACCATCTTCCAGGAGCGAG-3′ and 5′-CCAGCATCACCCCACTTGAT-3′. Relative gene expression was calculated using the ΔΔCt method with *b-actin* for mouse DCs, ubiquitin for mouse CD8^+^ T cells, and *GAPDH* for sheep leukocytes as the endogenous control housekeeping genes.

### Transwell migration assay.

Mouse DCs were obtained by density gradient enrichment from splenocytes or derived in vitro from BM Flt3-L cultures as previously described ([@bib38]). Human DCs were enriched using the human Blood Dendritic Cell Isolation kit II (Miltenyi Biotec). Sheep DCs were enriched by density gradient. Cells were resuspended in migration medium (0.5% BSA in RPMI) and distributed in the upper chamber of a 24 Transwell system insert (5-µm pore size; Corning). The lower chamber was filled with migration medium alone or containing 300 ng/ml of mouse recombinant XCL1 (R&D Systems) for mouse cells, 500 ng/ml of human recombinant XCL1 (R&D Systems) for human cells, and 100 ng/ml of recombinant mouse XCL1 for sheep cells. Cells were incubated for 3--4 h at 37°C in 5% CO~2~. A constant number of polybead polystyrene microspheres (Polyscience) was added in each lower chamber before harvesting migrated cells. Migrated cells were then stained and analyzed by flow cytometry. A constant event of microspheres for each well was acquired to evaluate the absolute number of cells recovered after migration. The percentage of migrated cells was calculated by the following formula for each subset: \[number of cells having migrated in response to XCL-1 − number of cells having migrated spontaneously\]/\[total number of input cells\] × 100. All experiments were performed with duplicate wells.

### Multianalyte profiling in supernatant from mouse CD8^+^ T cells.

2 × 10^5^ sorted naive CD8^+^ T cells and T~IM~ were stimulated for 6 h with the NP68 peptide at a concentration of 10 nM in 200 µl of medium. Supernatants were analyzed using Rodent MAP 1.0 (Rules Based Medicine).

### Infections with *Lm.*

The *Lm* WT strain 10403S and the *Lm* strain that had been engineered to express OVA (*Lm*-OVA; gift from Grégoire Lauvau, Albert Einstein College of Medicine, Bronx, NY) were prepared from clones grown from organs of infected mice. Stocks of bacteria were kept frozen at −80°C. For infections, a sample of the frozen stock was grown to a logarithmic phase (OD~600~ = 0.05--0.15) in broth heart infusion (BHI) medium (Sigma-Aldrich), diluted in PBS, and injected into the retroorbital vein. Bacterial loads in organs were evaluated after infection of mice with one LD~50~ of WT *Lm* (5 × 10^4^ bacteria). CD8^+^ T cell responses were measured in animals infected with 0.1 LD~50~ of *Lm*-OVA (5 × 10^3^ bacteria). The dose of *Lm* injected was confirmed by CFU counting of the inoculum. To measure bacterial titers, spleens and livers were harvested at day 3 and dissociated on nylon meshes in 5 ml of dissociation buffer (0.2% NP-40). Serial dilutions were performed and plated onto BHI agar plates. For analysis of *Lm*-specific CD8^+^ T cell responses at day 4, OVA-specific CD8^+^ T cells were readily detected using OVA-iTag-H-2K^b^-SIINFEKL PE-conjugated MHC class I tetramers (Beckman Coulter).

### Phylogenetic analysis.

12 representatives of XCR1 sequences were retrieved from Ensembl genome assemblies of relevant vertebrate species. No good candidate for XCR1 counterpart was found in other phyla. Chromosomal locations were obtained from Ensembl (November 2009 release). Conserved syntenies were searched manually in Ensembl and with the Genomicus tool (<http://www.dyogen.ens.fr/genomicus/cgi-bin/search.pl>). The amino acid sequences of XCR1 domain were aligned using ClustalW and Mega4 programs. Any site at which the alignment introduces a gap in any sequence was excluded, and a comparable set of sites was therefore used for the phylogenetic analyses. The phylogenetic analysis was made using two methods: NJ and parsimony using the MEGA 4 program ([@bib40]).

### Online supplemental material.

Fig. S1 documents the expression pattern of *XCL1* in mouse NK cells, mouse T~CM~, and human CD8^+^ T cells during viral infections. Fig. S2 shows the alignment of XCR1 protein sequences and the Maximum Parsimony phylogenetic analysis of *Xcr1* evolution in vertebrates. Online supplemental material is available at <http://www.jem.org/cgi/content/full/jem.20100223/DC1>.
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